Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Science Funding Bill Passes a Split House, Despite Scientist Opposition

May 22, 2015 | by Seth Augenstein, Digital Reporter | News | Comments

The American Competes Reauthorization Act of 2015 was passed by a split House of Representatives Wednesday, amid opposition from a wide swath of the scientific community. The passage also came after hours of negotiations over the bill, which Republicans have said would keep overall federal spending flat. Read more..

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Proteins May Slow Memory Loss in People with Alzheimer's

May 22, 2015 10:12 am | by Iowa State University | News | Comments

Certain proteins may slow the devastating memory loss caused by Alzheimer’s disease, according to a groundbreaking Iowa State University study. Read more...

TOPICS:

Confronting the Creep of Opioid Abuse

May 22, 2015 9:56 am | by Clea Simon, Harvard Correspondent | News | Comments

The good news: There is hope. The bad news: not enough people are aware of it. With opioid abuse on the rise, a panel of medical and policy officials convened on Monday at the Harvard T.H. Chan School of Public Health to discuss the growing problem, specifically the results of a national poll by The Boston Globe and the Chan School. Read more...

TOPICS:

Doctor Fights Overpopulation with Nonsurgical Contraceptive

May 22, 2015 9:40 am | by Seth Augenstein, Digital Reporter | News | Comments

An Oregon doctor is researching a non-surgical, permanent contraceptive method for women in developing countries, with some funding from the Gates Foundation. The work is being done with an eye toward curbing overpopulation, and to improve quality of life in impoverished countries, they said. Read more..

TOPICS:
Advertisement

Guinea Reports 27 New Ebola Cases after Previous Lull

May 22, 2015 8:49 am | by The Associated Press | News | Comments

Authorities in the country where the Ebola epidemic began are concerned about a new outbreak of cases just as officials hoped the crisis was coming under control. Read more...

TOPICS:

1950s Drug is Future Heart Treatment

May 22, 2015 8:46 am | by University of Oxford | News | Comments

Researchers have found a promising future treatment for heart disease, going back to a drug first developed in 1950. Read more...

TOPICS:

Freshly Squeezed Vaccines

May 22, 2015 8:39 am | by MIT | News | Comments

Researchers have shown that they can use a microfluidic cell-squeezing device to introduce specific antigens inside the immune system’s B cells. Read more...

TOPICS:

Shining a New Light on The Immune System

May 22, 2015 8:24 am | by University of St. Andrews | News | Comments

Researchers used a light scattering technique to identify important types of white blood cells. Read more...

TOPICS:

Potential New Drug Target for the Treatment of Rheumatoid Arthritis

May 21, 2015 1:40 pm | News | Comments

Researchers at the La Jolla Institute for Allergy and Immunology, in collaboration with colleagues the University of California, San Diego, identified a novel drug target for the treatment of rheumatoid arthritis that focuses on the cells that are directly responsible for the cartilage damage in affected joints. Read more...

TOPICS:
Advertisement

New Data on Boehringer Ingelheim's COPD Treatment

May 21, 2015 1:30 pm | News | Comments

Boehringer Ingelheim announced new data analyses from the pivotal Phase III TONADO 1&2 studies (NCT01431274/NCT01431287), which explored the efficacy and safety of investigational tiotropium/olodaterol delivered via the Respimat inhaler for chronic obstructive pulmonary disease (COPD) compared to the individual components (tiotropium and olodaterol delivered by the RESPIMAT inhaler) alone. Read more...

TOPICS:

Novartis Announces COPD Phase 3 Results

May 21, 2015 1:23 pm | News | Comments

Today, Novartis announced for the first time detailed results from its phase III EXPEDITION trial program for QVA149 (indacaterol/glycopyrronium) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). Read more...

TOPICS:

Emmes Announces FDA Clearance of New Medical Device

May 21, 2015 1:18 pm | News | Comments

The Emmes Corporation today announced that the U.S. Food and Drug Administration (FDA) has given marketing clearance for a new device that allows doctors to more accurately assess children's weight without the use of a weight scale. Weight estimates are used in emergency situations and in developing countries where scales may not be available. Read more...

TOPICS:

Injected T Cells from Bone Marrow Treat Multiple Myeloma, Pilot Study Finds

May 21, 2015 1:12 pm | by Stephanie Guzowski, Editor | Articles | Comments

In a first small clinical trial of its kind, researchers harnessed T cells from patients’ own bone marrow to treat multiple myeloma and provide immune protection for up to a year, according to a study published this week in Science Translational Medicine. Read more...

TOPICS:

FDA Proposes to Know More About Antibiotic Use in Animals

May 21, 2015 9:51 am | by Mary Clare Jalonick, Associated Press | News | Comments

The Food and Drug Administration is moving to collect more information on antibiotics used in animals that become meat. It's an effort to stem antibiotic-resistant diseases. Read more...

TOPICS:

Researchers Discover a Treatment to Block MS Progression

May 21, 2015 9:46 am | by University of Montreal | News | Comments

There is no effective cure for MS. Read more...

Chemo Before Surgery Benefits Patients with Advanced Ovarian Cancer

May 21, 2015 9:39 am | by Cancer Research UK | News | Comments

550 women with the disease took part in the trial, with 276 given the standard treatment of surgery followed by six cycles of chemotherapy, and 274 had surgery after three cycles of chemotherapy. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading